LAURA PINO: Open Payments
NPI 1023094794 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 32 payments from 15 companies in 2025. Trend: 2023 $377 · 2024 $971 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $206 |
| Novo Nordisk Inc | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $89 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: BOTOX, UBRELVY, BREZTRI, SHINGRIX, Rybelsus, Ozempic, REXULTI, INSPIRE.
Industry payments across NJ — which companies pay providers there.
